Summit Global Investments’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,955
| Closed | -$237K | – | 477 |
|
|
2025
Q1 | $237K | Sell |
7,955
-153
| -2% | -$4.56K | 0.02% | 392 |
|
|
2024
Q4 | $232K | Buy |
+8,108
| New | +$232K | 0.01% | 487 |
|
|
2023
Q2 | – | Sell |
-96,485
| Closed | -$2.32M | – | 552 |
|
|
2023
Q1 | $2.32M | Sell |
96,485
-1,816
| -2% | -$43.6K | 0.18% | 120 |
|
|
2022
Q4 | $2.28M | Buy |
98,301
+367
| +0.4% | +$8.52K | 0.19% | 124 |
|
|
2022
Q3 | $1.57M | Sell |
97,934
-12,672
| -11% | -$203K | 0.15% | 153 |
|
|
2022
Q2 | $1.96M | Buy |
110,606
+56,306
| +104% | +$998K | 0.17% | 136 |
|
|
2022
Q1 | $1.11M | Sell |
54,300
-25,800
| -32% | -$526K | 0.08% | 222 |
|
|
2021
Q4 | $1.5M | Buy |
80,100
+11,100
| +16% | +$207K | 0.1% | 182 |
|
|
2021
Q3 | $1.36M | Buy |
69,000
+40,300
| +140% | +$795K | 0.1% | 167 |
|
|
2021
Q2 | $678K | Buy |
+28,700
| New | +$678K | 0.04% | 289 |
|